Clinical Trials

At Lehigh Valley Health Network, we are committed to providing our patients and community with the best possible care and treatments. Our research scientists are integrated with our clinical departments for a comprehensive, collaborative approach to research. Have a question about clinical trials? Contact the Network Office of Research and Innovation at 610-402-9543.

Showing 60 of 137 Clinical Trials

Clinical Research Trial

EAA181 Multiple Myeloma

Effective Quadruplet Utilization After Treatment Evaluation (EQUATE): A Randomized Phase III Trial for Newly Diagnosed Multiple Myeloma Not Intended for Early Autologous Transplantation

Doctor(s) Running This Study
Maged F. Khalil, MD
Clinical Research Trial

EAA181 Multiple Myeloma

Effective Quadruplet Utilization After Treatment Evaluation (EQUATE): A Randomized Phase III Trial for Newly Diagnosed Multiple Myeloma Not Intended for Early Autologous Transplantation

Doctor(s) Running This Study
Maged F. Khalil, MD
Clinical Research Trial

SWOG-S1501

PROSPECTIVE OBSERVATIONAL COHORT STUDY OF PATIENTS WITH METASTATIC HER-2+ BREAST CANCER AT RISK OF CARDIAC TOXICITY

Doctor(s) Running This Study
Maged F. Khalil, MD
Clinical Research Trial

SWOG-S1501

PROSPECTIVE OBSERVATIONAL COHORT STUDY OF PATIENTS WITH METASTATIC HER-2+ BREAST CANCER AT RISK OF CARDIAC TOXICITY

Doctor(s) Running This Study
Maged F. Khalil, MD
Clinical Research Trial

A092205 Head and Neck Cancers

Randomized Phase III Trial of Pembrolizumab vs. Pembrolizumab/Cetuximab in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma with Platinum Refractory Disease

Doctor(s) Running This Study
Maged F. Khalil, MD
Clinical Research Trial

A092205 Head and Neck Cancers

Randomized Phase III Trial of Pembrolizumab vs. Pembrolizumab/Cetuximab in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma with Platinum Refractory Disease

Doctor(s) Running This Study
Maged F. Khalil, MD